333 Ludlow Street, South Tower, 3rd Floor
Stamford, CT 06902
Sema4 is a health information company founded on the idea that more information, deeper analysis, and increased engagement will improve the diagnosis, treatment, and prevention of disease. A Mount Sinai Health System venture based in Stamford, Conn., Sema4 is enabling physicians and consumers to more seamlessly engage the digital universe of data, from genome test results and clinical records to wearable sensor metrics and more. The company currently offers advanced genome-based diagnostics for reproductive health and is building predictive models of complex disease. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.
Sema4’s breakthrough insights and products arise out of decades of real-world clinical knowledge and academic research. The Sema4 team is comprised of leading scientists in complex genomics, cancer research and development, systems and network biology, and population genomics. Learn more at https://sema4genomics.com/research/#publications